|
|
Exchange: |
Nasdaq Small Cap |
Security
Type: |
Common |
Shares
Out: |
15,080,000 |
Market
Cap: |
26.54(M) |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$1.43 - $2.3 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Cumberland Pharmaceuticals is a pharmaceutical company engaged on the acquisition, development and commercialization of prescription products. Co.'s portfolio of brands include: Acetadote® (acetylcysteine) injection, for the treatment of acetaminophen poisoning; Caldolor® (ibuprofen) injection, for the treatment of pain and fever; Kristalose® (lactulose) for the treatment of constipation; Omeclamox®-Pak, (omeprazole, clarithromycin, amoxicillin) for the treatment of Helicobacter pylori infection and related duodenal ulcer disease; and Vaprisol® (conivaptan) injection, to raise serum sodium levels in hospitalized patients with euvolemic and hypervolemic hyponatremia.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
30,318 |
Total Buy Value |
$0 |
$0 |
$0 |
$70,308 |
Total People Bought |
0 |
0 |
0 |
4 |
Total Buy Transactions |
0 |
0 |
0 |
496 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Galante Joseph C |
Director |
|
2022-09-19 |
4 |
AB |
$2.56 |
$166 |
D/D |
65 |
52,491 |
|
4% |
|
Jones James |
Director |
|
2022-09-19 |
4 |
AB |
$2.56 |
$79 |
D/D |
31 |
24,045 |
|
4% |
|
Young Caroline |
Director |
|
2022-09-19 |
4 |
AB |
$2.56 |
$51 |
D/D |
20 |
18,188 |
|
4% |
|
Krogulski Kenneth |
Director |
|
2022-09-19 |
4 |
AB |
$2.56 |
$269 |
D/D |
105 |
196,550 |
|
4% |
|
Galante Joseph C |
Director |
|
2022-09-16 |
4 |
AB |
$2.49 |
$174 |
D/D |
70 |
52,426 |
|
3% |
|
Jones James |
Director |
|
2022-09-16 |
4 |
AB |
$2.49 |
$85 |
D/D |
34 |
24,014 |
|
3% |
|
Young Caroline |
Director |
|
2022-09-16 |
4 |
AB |
$2.49 |
$55 |
D/D |
22 |
18,168 |
|
3% |
|
Krogulski Kenneth |
Director |
|
2022-09-16 |
4 |
AB |
$2.49 |
$286 |
D/D |
115 |
196,445 |
|
3% |
|
Galante Joseph C |
Director |
|
2022-09-15 |
4 |
AB |
$2.47 |
$173 |
D/D |
70 |
52,356 |
|
9% |
|
Jones James |
Director |
|
2022-09-15 |
4 |
AB |
$2.47 |
$84 |
D/D |
34 |
23,980 |
|
9% |
|
Young Caroline |
Director |
|
2022-09-15 |
4 |
AB |
$2.47 |
$54 |
D/D |
22 |
18,146 |
|
9% |
|
Krogulski Kenneth |
Director |
|
2022-09-15 |
4 |
AB |
$2.47 |
$284 |
D/D |
115 |
196,330 |
|
9% |
|
Galante Joseph C |
Director |
|
2022-09-14 |
4 |
AB |
$2.51 |
$176 |
D/D |
70 |
52,286 |
|
14% |
|
Jones James |
Director |
|
2022-09-14 |
4 |
AB |
$2.51 |
$85 |
D/D |
34 |
23,946 |
|
14% |
|
Young Caroline |
Director |
|
2022-09-14 |
4 |
AB |
$2.51 |
$55 |
D/D |
22 |
18,124 |
|
14% |
|
Krogulski Kenneth |
Director |
|
2022-09-14 |
4 |
AB |
$2.51 |
$289 |
D/D |
115 |
196,215 |
|
14% |
|
Galante Joseph C |
Director |
|
2022-09-13 |
4 |
AB |
$2.45 |
$172 |
D/D |
70 |
52,216 |
|
11% |
|
Jones James |
Director |
|
2022-09-13 |
4 |
AB |
$2.45 |
$83 |
D/D |
34 |
23,912 |
|
11% |
|
Young Caroline |
Director |
|
2022-09-13 |
4 |
AB |
$2.45 |
$54 |
D/D |
22 |
18,102 |
|
11% |
|
Krogulski Kenneth |
Director |
|
2022-09-13 |
4 |
AB |
$2.45 |
$282 |
D/D |
115 |
196,100 |
|
11% |
|
Galante Joseph C |
Director |
|
2022-09-12 |
4 |
AB |
$2.46 |
$172 |
D/D |
70 |
52,146 |
|
17% |
|
Jones James |
Director |
|
2022-09-12 |
4 |
AB |
$2.46 |
$84 |
D/D |
34 |
23,878 |
|
17% |
|
Young Caroline |
Director |
|
2022-09-12 |
4 |
AB |
$2.46 |
$54 |
D/D |
22 |
18,080 |
|
17% |
|
Krogulski Kenneth |
Director |
|
2022-09-12 |
4 |
AB |
$2.46 |
$283 |
D/D |
115 |
195,985 |
|
17% |
|
Galante Joseph C |
Director |
|
2022-09-09 |
4 |
AB |
$2.21 |
$155 |
D/D |
70 |
52,076 |
|
16% |
|
1400 Records found
|
|
Page 6 of 56 |
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Acquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|